COMMENTARY

MHLW Panel Elaborating Rules for Clinical Research Law, “Scholarship Donations” to Be a Major Focus

August 21, 2017
By Hiroyasu Onishi The Clinical Research Law was enacted and promulgated in April, and a dedicated health ministry panel kicked off earlier this month to discuss the specifics before its enforcement sometime within a year of the promulgation. The largest…

To read the full story

Related Article

COMMENTARY

By Shinya Sato

As 2019 rolls in, we expect to see a flurry of approvals in the Japanese regenerative medicine arena, with regulatory decisions anticipated by the end of the year for Novartis Pharma’s CAR-T therapy and many more products, which could bring…

Takeda Pharmaceutical completed the £46 billion acquisition of Shire on January 8, vaulting itself into the top 10 league of…

By Gregory Ng

To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…

By Reiji Anasako

While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…